# US regulator warns of potential eye-condition risk linked to GLP-1 drugs

https://mins.news/en/item/135928

- CNN, 2026-11-09 17:05 UTC
- Health
- Original: https://www.cnn.com/2026/11/09/health/glp1-vision-loss-fda-warning?Date=20261109&Profile=CNN

> The US health regulator notified patients and healthcare providers of a potential higher risk of a serious eye condition associated with GLP-1 drugs used for weight loss and diabetes.

## Related coverage

- [FDA orders new eye-condition warning for Ozempic, Wegovy and other GLP-1 drugs](https://mins.news/en/video/137832) — ABC News, 2026-11-10
- [FDA adds rare vision-loss warning to popular GLP-1 drugs](https://mins.news/en/item/136483) — The Associated Press, 2026-11-10
- [US regulator orders weight-loss drugs to add vision-loss warning](https://mins.news/en/item/135949) — euronews, 2026-11-09
- [US FDA orders new eye-risk warnings for Ozempic and Zepbound](https://mins.news/en/item/135774) — Reuters, 2026-11-09
